Barclays »

Citius Pharmaceuticals shares owned by Barclays

Quarter-by-quarter ownership of Citius Pharmaceuticals (CTXR) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Citius Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Citius Pharmaceuticals held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Citius Pharmaceuticals by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $662 1.1k 0.60
2025-03-31 $0 29 0.00

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Citius Pharmaceuticals

Geode Capital Management
Vanguard Capital Management
Miller Financial Services
Citadel Advisors
Jane Street
Vanguard Fiduciary Trust
BlackRock
Northern Trust
XTX Topco
Asset Advisory Group
BostonPremier Wealth
UBS Group
LPL Financial
State Street Corporation
Virtu Financial

View all funds holding Citius Pharmaceuticals